Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor

Journal of Clinical Investigation

Volumn 104, Issue 9, 1999, Pages 1277-1285

  Bousquet, Corinne ^a   Susini, Christiane ^b   Melmed, Shlomo ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSERM   (France)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CYTOKINE; HYBRID PROTEIN; LEUKEMIA INHIBITORY FACTOR; PHOSPHOTRANSFERASE; PROOPIOMELANOCORTIN; PROTEASOME; PROTEIN; PROTEIN TYROSINE PHOSPHATASE; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; DEPHOSPHORYLATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 0032743225     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7924     Document Type: Article

References (36)

1. Hibi, M., Nakajima, K., and Hirano, T. 1996. IL-6 cytokine family and signal transduction: a model of the cytokine system. J. Mol. Med. 74:1-12.
2. Chesnokova, V., Auernhammer, C.J., and Melmed, S. 1998. Murine LIF gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology. 139:2209-2216.
3. Akita, S., et al. 1995. Human and murine pituitary expression of LIF: novel intrapituitary regulation of adrenocoeticotropin synthesis and secretion. J. Clin. Invest. 95:1288-1298.
4. Wang, Z., Ren, S.G., and Melmed, S. 1996. Hypothalamic and pituitary LIF gene expression in-vivo: a novel endocoxin-inducible neuroendocrine interface. Endocrinology. 137:2947-2953.
5. Bousquet, C., Ray, D.W., and Melmed, S. 1997. A common proopiomelanocortin element mediates LIF and CRH transcriptional synergy. J. Biol. Chem. 272:10551-10557.
6. Ihle, J.N. 1995. The janus protein tyrosine kinase family and its role in cytokine signaling. Adv. Immunol. 60:1-35.
7. Horvath, C.M., and Darnell, J.E., Jr. 1997. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr. Opm. Cell Biol. 9:233-239.
8. Bousquet, C., and Melmed, S. 1999. Critical role for STAT3 in murine pituitary ACTH leukemia inhibitory factor (LIF) signaling. J. Biol. Chem. 274:10723-10730.
9. Fauman, E.B., and Saper, M.A. 1996. Structure and function of the protein tyrosine phosphatases. Trends Biochem. Sci. 21:413-417.
10. You, M., and Zhao, Z. 1997. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor-and interferon-γ-stimulated activation of STAT transcription factors in HeLa cells. J. Biol. Chem. 272:23376-23381.
11. Ram, P.A., and Waxman, D.J. 1997. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J. Biol. Chem. 272:17694-17702.
12. Hackett, R.H., et al. 1997. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of JAK2 and STAT proteins. J. Biol. Chem. 272:11128-11132.
13. Jiao, H., et al. 1996. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain containing protein tyrosine phosphatase SHP-1. Mol. Cell. Biol. 16:6985-6992.
14. Klingmuller, U., Lorenz, U., Cantley, L.C., Neel, B.G., and Lodish, H.F. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:729-738.
15. Hilton, D.J., Richardson, R.T., Alexander, W.S., Viney, E.M., Willson, T.A., et al. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA. 95:114-119.
16. Adams, J.E., et al. 1998. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273:1285-1287.
17. Bjorbaek, C., Elmquist, J.K., Frantz, J.D., Shoelson, S.E., and Flier J.S. 1998. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell. 1:619-625.
18. Auernhammer, C.J., Chesnokova, V., Bousquet, C., and Melmed, S. 1998. Pituitary corticotroph SOCS-3: novel intracellular regulation of cytokine-mediated proopiomelanocortin gene expression and ACTH secretion. Mol. Endocrinol. 12:954-961.
19. Auernhammer, C.J., Bousquet, C., and Melmed, S. 1999. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc. Natl. Acad. Sci. USA. 96:6964-6969.
20. Bousquet, C., et al. 1998. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1. J. Biol. Chem. 273:7099-7106.
21. Ray, D.W., Ren, S.G., and Melmed, S. 1996. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J. Clin. Invest. 97:1852-1859.
22. Boutillier, A.L., Gaiddon, C., Lorang, D., Roberts, J.L., and Loeffler, J.P. 1998. Transcriptional activation of the proopiomelanocortin gene by cyclic AMP-responsive element binding protein. Pituitary. 1:33-43.
23. Feng, G.S., and Pawson, T. 1994. Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction. Trends Genet. 10:54-58.
24. David, M., Chen, H.E., Goelz, S., Larner, A.C., and Nell, B.G. 1995. Differential regulation of the alpha/beta interferon-stimulated Jak-Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 15:7050-7058.
25. Yetter, A., et al. 1995. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J. Biol. Chem. 270:18179-18182.
26. Damen, J.E., et al. 1995. Tyrosine 343 in the erythropoierin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14:5557-5568.
27. D'Ambrosio, D., et al. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science. 268:293-297.
28. Pei, D., Lorenz, U., Klingmuller, U., Neel, B.G., and Walsh, C.T. 1994. Intramolecular regulation of protein tyrosine phosphatase SH-PTP1: a new function for Src homology 2 domains. Biochemistry. 33:15483-15493.
29. Yi, T., Zhang, J., Miura, O., and Ihle, J.N. 1995. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites. Blood 85:87-95.
30. Endo, T.A., et al. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 387:921-924.
31. Yoshimura, A., et al. 1995. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14:2816-2826.
32. Narazaki, M., et al. 1998. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc. Natl. Acad. Sci. USA. 95:13130-13134.
33. Nicholson, S.E., et al. 1999. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18:375-385.
34. Kamura, T., et al. 1998. The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:3872-3881.
35. Cohney, S.J., et al. 1999. SOCS-3 is tyrosine phosporylated in response to interleukin-2 and suppresses STATS phosphorylation and lymphocyte proliferation. Mol. Cell. Biol. 19:4980-4988.
36. Kim, T.K., and Maniatis, T. 1996. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science. 273:1717-1719.